By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Graduation Day from a Clot-Preventing Clinical Trial
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Education > Graduation Day from a Clot-Preventing Clinical Trial
Medical Education

Graduation Day from a Clot-Preventing Clinical Trial

Andrew Schorr
Andrew Schorr
Share
5 Min Read
SHARE

It’s been six months since a warm, swollen right calf sent me to the emergency room at midnight. Ultrasound showed I had a blog clot in my right leg and an asymptomatic one above the knee in my left. Everyone said it was a good thing I sought care because the complication of a pulmonary embolism – when the clot moves “north,” is a really bad – even fatal – event. The whole experience of having a clot and then being hospitalized for a day and a half was surreal for me.

It’s been six months since a warm, swollen right calf sent me to the emergency room at midnight. Ultrasound showed I had a blog clot in my right leg and an asymptomatic one above the knee in my left. Everyone said it was a good thing I sought care because the complication of a pulmonary embolism – when the clot moves “north,” is a really bad – even fatal – event. The whole experience of having a clot and then being hospitalized for a day and a half was surreal for me. Later, I found out it wasn’t just that I was getting older – 61 – but also that I was a cancer survivor that put me at higher risk. Later still, I had a genetic test that showed I had a gene that set me up for DVTs, or deep vein thrombosis, as these clots are called in medical jargon.

As regular readers may recall, a clinical trial coordinator came by as I was about to leave the hospital and approached me about joining a trial for an investigation medicine to lower my risk for future DVT’s. Having benefited from a leukemia phase II trial and having preached enrollment in trials for years I knew I better sign up and not be a hypocrite.

Soon I found myself taking two green pills a day – Coumadin, the old blood thinning standby, and two yellow pills, the experimental Edoxoban. Actually that’s not quite right. Either the green pills or the yellow pills might have been no medicine at all, a placebo. Neither I nor my healthcare team knew which medicine I was on, the old or the new.

More Read

biopharma beat diagnostics
BioPharma Beat: The Promise of Diagnostics and Precision Medicine
10 Lessons I’ve Learned from Premature Babies in the NICU
Patient Satisfaction and P4P – Three Things Doctors Need to Know
Swimmers Beware! Drowning 101…
A story about the pharmaceutical industry, doctors and patients

Dutifully I have taken my pills every day but one, when I got confused on an overnight flight to Europe. I have had no new DVT’s. What I did have after that flight was “post thrombotic syndrome” where my ankles were really red and swollen for a few days. Compression socks, a lot of water, and walking around seemed to prevent that on the long flights home.

Just today I “graduated” from the clinical trial – or at least taking daily medicine. My doctors feel the risks and cost of medicine for life are not worth it UNLESS I have another DVT. Of course, I am a little skittish about that. No, I don’t want to take unneeded medicine. But I also don’t want to risk one of those pulmonary embolisms. I guess we all face health risks as we grow older. So we just do our best and try not to worry about what could happen but probably won’t.

I’ll be followed for another year by the trial team. They took four tubes of blood today on my “graduation” day. I am happy to help, although I battled snow and ice (uncommon in Seattle) to get to them today. The goal, of course, is to win approval for a safe and effective medicine that is much less tricky to use than Coumadin, which has risks of its own. I hope my participation has helped.

I continue to be a believer in participation in clinical trials. That’s how we patients help advance potentially better medicines for all of us. My participation was no big deal and just maybe it was the yellow pills, the new drug, that were the active ones for me and I was getting “tomorrow’s medicine today.” So I would urge anyone to consider participating in a trial. You’ll get monitored closely and feel like you are doing good to help yourself and others.

For more on DVTs, listen to the Patient Power program:

Deep Vein Thrombosis: Knowing Your Risk for Blood Clots

TAGGED:clinical trialsdeep vein thrombosisDVT
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Understanding the Connection Between Chronic Pain and Mental Health: A Path to Holistic Healing
Understanding the Connection Between Chronic Pain and Mental Health: A Path to Holistic Healing
Anxiety Mental Health
July 6, 2026
Florida Nurses Face Growing Licensing Risks: Understanding the Investigation Process and How to Protect Your Career
Florida Nurses Face Growing Licensing Risks: Understanding the Investigation Process and How to Protect Your Career
Nursing Policy & Law
July 2, 2026
Most Clinician Wellness Programs Are Built for a Schedule Nurses Don't Have
Most Clinician Wellness Programs Are Built for a Schedule Nurses Don’t Have
Career Nursing
July 2, 2026
Veneers vs. Crowns vs. Bonding: Understanding Cosmetic Options
Veneers vs. Crowns vs. Bonding: Understanding Cosmetic Options
Dental health Specialties
June 23, 2026

You Might also Like

Healthcare Careers With Real Potential

August 16, 2016

Health Literacy Resources

October 30, 2012

Video Player is Updated With New Videos!

January 19, 2012
New Rx Talk Time
BusinessMedical Education

Patient Nonadherence: A Rational Reaction to Sub-Optimal Physician-Patient Communication

July 7, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?